By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CureVac GmbH 

Paul-Ehrlich-Str. 15

Tübingen    72076  Germany
Phone: 49-7071-92053-0 Fax: 49-7071-92053-11



Company News
CureVac Appoints Pierre Kemula As Chief Financial Officer 10/11/2016 6:36:11 AM
CureVac Release: Study In Peer-Reviewed Journal Vaccine Demonstrates Decoding Mode Of Action Of mRNA Vaccines 7/14/2016 8:52:56 AM
CureVac Appoints Leading Experts To Its Scientific Advisory Board 3/30/2016 7:42:20 AM
CureVac Strengthens Supervisory Board To Support Global Growth Opportunities And mRNA Product Expansion 3/21/2016 8:26:38 AM
CureVac Announces "MERAN" Has Been Approved By The WHO As Suffix For Mrna Drug Substances 2/18/2016 10:29:33 AM
CureVac To Present At The 34th Annual J.P. Morgan Healthcare Conference 12/21/2015 11:48:17 AM
CureVac Banks $110 Million 11/3/2015 6:14:49 AM
IAVI And CureVac Partner To Accelerate Development And Testing Of AIDS Vaccine Candidates 9/10/2015 6:22:25 AM
CureVac Sets Up Shop in Cambridge, Mass. to Expand mRNA Therapies 9/10/2015 5:59:28 AM
CureVac To Present At BioCentury's 22nd Annual NewsMakers In The Biotech Industry Conference 9/3/2015 9:34:32 AM